The ocular hypertension market is expected to witness growth driven by the increasing prevalence of elevated intraocular pressure (IOP), growing awareness of its association with primary open-angle glaucoma (POAG), and
Ocular Hypertension Market is Expected to Witness Growth by 2034 Owing to the Rising Prevalence of Elevated Intraocular Pressure and Growing Focus on Glaucoma Prevention | DelveInsight
The Key Hypercholesterolemia Companies in the market include – Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx Therapeutics, Chroma Medicine, Verve Therapeutics, Inc, Vaxxinity, Inc, Arrowhead Pharmaceuticals, Merck Sharp &
(Albany, New York) – November 03, 2026: As per DelveInsight’s assessment, globally, Heart Failure pipeline constitutes 70+ key companies continuously working towards developing 75+ Heart Failure treatment therapies, analysis of
The Key 22q11.2 Deletion Syndrome Companies in the market include – Sumitomo Pharma, Enzyvant, Roivant Sciences, Zynerba Pharmaceuticals, Harmony Biosciences, Nobias Therapeutics, and others. (Albany, US), November 3, 2026 –
The Key Frontotemporal Dementia Companies in the market include – Passage Bio, Denali Therapeutics, Vesper Bio, AviadoBio, Transposon Therapeutics, Alector,
The Key Metastatic HR+/HER2− Breast Cancer Companies in the market include – Novartis, Eli Lilly, AstraZeneca, Pfizer, Sermonix Pharmaceuticals, Veru
(Albany, New York) – November 03, 2026: As per DelveInsight’s assessment, globally, Cutaneous Lupus Erythematosus pipeline constitutes 8+ key companies
The Key Gastric Cancer Companies in the market include – AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharmaceuticals, BeiGene, and
The Key Ovarian Cancer Companies in the market include – pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio/Genmab, Mario
The Mantle Cell Lymphoma Clinical Trial analysis report delivers important insights into ongoing research on 45+ pipeline drugs, clinical strategies,
